Recent Updates
Recently added Catalysts
SLDB

Solid Biosciences Present American Society Gene And Cell Therapy

Key Takeaway: Solid Biosciences Present American Society Gene And Cell Therapy
Price reaction · baseline $6.25 (2023-05-15 close) · hit after-hours · clean, no other SLDB news in the window
day 0 close
+0.2%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+116%
120-day peak, hindsight
Typical move
7.4%
average across 7 past catalysts
Cash runway
~21 mo
Low dilution risk
Lead asset
carmustine
Phase 3 · Lymphoma

Full Press Release Details

Solid Biosciences Present American Society Gene And Cell Therapy.
Last updated: May 16, 2023